In the B16F10 syngeneic melanoma mouse model, NH125 or PD-1 mAb lonely treatment inhibited tumor growth, while co-treatment with NH125 and PD-1 mAb achieved better efficacy, as evidenced by the greater decreases in tumor volume and tumor weight (figure 8B–D). The gene discussed is PDCD1; the disease is melanoma.